After reaching the destined number of cell divisions, some of them might lose the capacity to activate the “kill switch”, and enter a phase called Senescence. In this phase, a cell can neither divide, nor kill itself. In other words, they become “dying cells”, rather than “dead cells”. Scientifically, these are called
About The Author
Related Posts
Senolytics in the News
- Fighting ageing with immune checkpoint blockade
- Despite Their Scary Name, Some ‘Zombie’ Cells May Not Be All Bad
- Focus on frailty: New senolytic holds potential for sarcopenia treatment
- Progress in Emerging Alzheimer’s Therapeutics Based on Biology of Aging to be Highlighted in Session Moderated by Alzheimer’s Drug Discovery Foundation (ADDF) at 2022 Clinical Trials on Alzheimer’s Disease Conference
- Senolytic treatment shows promise in DME, wet AMD